Diabetic Heart Disease
Diabetic Heart Disease encompasses the broader spectrum of cardiovascular complications associated with diabetes, including coronary artery disease, heart failure, arrhythmias, microvascular dysfunction, and autonomic neuropathy. This session provides an integrated understanding of how diabetes accelerates cardiovascular pathology, emphasizing prevention, early detection, and optimized therapy. As practitioners increasingly seek a comprehensive cardiology conference, this session combines endocrine, metabolic, and cardiology perspectives.
The description explores mechanisms driving diabetic cardiovascular risk—insulin resistance, dyslipidemia, endothelial dysfunction, oxidative stress, and chronic inflammation. Participants will understand how these factors contribute to rapid plaque progression, silent ischemia, and atypical presentations of acute coronary syndromes. The session highlights how diabetes doubles or triples cardiovascular event risk and influences prognosis.
A central component focuses on diagnosing diabetic heart disease early using ECG, echocardiography, CMR, coronary CT angiography, biomarkers, and functional tests. The session explains how to detect microvascular dysfunction, autonomic neuropathy, silent ischemia, and structural abnormalities.
Participants will learn to implement advanced diabetic heart disease management strategies, including aggressive lipid-lowering, blood pressure control, glucose management using SGLT2 inhibitors and GLP-1 analogues, antiplatelet therapy, lifestyle modification, and cardiac rehabilitation. The session addresses complexities such as comorbid CKD, obesity, hypertension, and aging, which amplify risk.
Case-based discussions illustrate how to manage CAD in diabetes, optimize anti-anginal therapy, and implement team-based care involving endocrinologists, nephrologists, and cardiologists. Participants will examine evidence from major trials shaping therapy choices.
Future directions include precision medicine approaches, digital monitoring, metabolomics, and AI-enabled cardiovascular prediction models. By the end, attendees will develop a holistic, evidence-based framework for managing cardiovascular disease in diabetic patients.
Ready to Share Your Research?
Submit Your Abstract Here →Core Concepts in Diabetic Heart Disease
Mechanistic Drivers of Cardiovascular Risk
- Understanding metabolic, inflammatory, and endothelial pathways.
- Recognizing contributions to silent ischemia.
Diagnostic Tools Across Disease Spectrum
- Using imaging, biomarkers, and functional testing.
- Detecting early dysfunction before advanced disease develops.
Integrated Therapeutic Approaches
- Combining glycemic control with lipid and BP management.
- Incorporating SGLT2 inhibitors, GLP-1 agents, and lifestyle care.
Long-Term Risk Reduction
- Monitoring progression and adjusting therapy continually.
- Educating patients for better self-management.
Key Benefits in Clinical Practice
Lower Cardiovascular Events
Aggressive risk modification reduces MI and stroke.
Better Glycemic-Cardiac Alignment
Modern therapies improve outcomes across both domains.
Improved Quality of Life
Patients experience fewer symptoms and better function.
Holistic, Team-Based Care Integration
Coordinated care enhances management effectiveness.
Stronger Prevention Strategies
Risk factor reduction starts earlier and is more sustained.
Better Outcomes in High-Risk Groups
Older adults and multicomorbid patients benefit significantly.
Related Sessions You May Like
Join the Global Cardiology & Cardiovascular Science Community
Join leading cardiologists, cardiovascular scientists, and healthcare experts from around the world. Present your pioneering research and explore the latest breakthroughs in heart health, cardiovascular diseases, and cutting-edge treatments driving the future of cardiology.
